GHK-Cu for Dark Circles and Under-Eye Skin: What the Evidence Actually Shows
Published by AmpleLab Research
Search for GHK-Cu and dark circles, and you'll find the same claim repeated across dozens of skincare sites: a "1998 study" in which GHK-Cu eye cream, tested on 41 women over 12 weeks, outperformed vitamin K cream and reduced periorbital wrinkles by around 55%. We traced that claim back to its source, and it doesn't hold up.
This article covers what dark circles actually are, what the real underlying study says versus what's being claimed about it, and what GHK-Cu's genuine evidence base does and doesn't support for the eye area.
"Dark circles" is a description of an appearance, not a single cause, and the cause determines what could plausibly help. Three distinct mechanisms are usually involved, sometimes together in the same person:
Vascular: under-eye skin is among the thinnest on the body, and where it's thin enough, the underlying blood vessels show through, giving a bluish or purplish cast. Pigmentation: excess melanin in the area, whether genetic, from sun exposure, or post-inflammatory, produces a browner tone. Structural: volume loss around the eye, common with age, can create a hollow that casts its own shadow, an optical effect rather than a colour change in the skin itself.
Any ingredient's relevance depends on which of these is actually driving the appearance in a given person. This matters directly for what follows, because GHK-Cu's documented mechanism is most plausibly relevant to one of the three.
The widely-repeated "1998 eye cream study" traces back to one real paper, but the details being attributed to it don't match what the paper actually did.
A pilot study comparing topical vitamin C, a copper-binding peptide cream, and melatonin against tretinoin, examining effects on the ultrastructure of normal skin. 20 healthy subjects were involved, treated for one month, with creams applied to the extensor surface of the thigh. Outcomes measured were histologic and ultrastructural markers: procollagen synthesis, keratinocyte proliferation, and inflammatory markers in skin biopsies.
What this is not: not 41 women, not 12 weeks, not eye cream, not applied to periorbital skin, not a measurement of wrinkles, dark circles, or any eye-area outcome at all. It's a general skin biopsy study on the thigh. The "41 women, eye cream, 55% wrinkle reduction, beat vitamin K" version circulating across skincare marketing content does not match this paper, and we could not locate a separate study matching those specific details in the sources we could verify.
There is a smaller, genuine kernel behind the eye-cream claim: a GHK-Cu facial cream study was presented at the 2002 American Academy of Dermatology meeting (Leyden et al.), and some secondary summaries describe an eye cream component compared against a vitamin K cream. But this was a conference presentation, not a peer-reviewed published paper, which is meaningfully thinner evidence than "a study found," and it doesn't support the specific percentages attached to the 1998 paper.
We're flagging this in the same spirit as our article on GHK-Cu and stretch marks, where the same pattern showed up: a specific, precisely-cited study gets repeated across enough marketing content that it starts to feel verified, without actually checking out against the source.
GHK-Cu's genuine, well-documented mechanism is tissue remodelling: modulation of matrix metalloproteinases, stimulation of collagen and glycosaminoglycan production, and general dermal matrix support, the same mechanism covered in depth in our articles on GHK-Cu and scarring and GHK-Cu and stretch marks. That mechanism is genuinely relevant to one of the three dark circle causes described above: the vascular type, where thin skin allows underlying vessels to show through. Thickening and reinforcing that skin structurally is a mechanistically plausible way to reduce vessel visibility, though dedicated studies testing that specific outcome, GHK-Cu applied to periorbital skin with vessel visibility as the measured endpoint, do not appear to exist.
It's not a plausible mechanism for the pigmentation type, GHK-Cu's evidence base doesn't include melanin-suppressing activity the way ingredients like niacinamide or tranexamic acid do, and it's not a mechanism for the structural, volume-loss type, which is an anatomical hollowing that a topical dermal-remodelling active doesn't address. Whether GHK-Cu is a reasonable thing to try for dark circles genuinely depends on which type someone actually has, which a mirror alone often can't tell you but a dermatologist can.
Periorbital skin is thinner and more reactive than the rest of the face, regardless of which active is being applied. A smaller amount than a standard facial application is the sensible default, applied with a light touch rather than rubbed in, and kept away from direct contact with the eye itself.
We're not aware of dedicated periorbital tolerability testing specific to 1% GHK-Cu Face and Skin Serum. A patch test on a less sensitive area of skin first is a reasonable precaution before using any new active this close to the eyes.
The honest position
The specific "GHK-Cu eye cream study" cited across skincare content doesn't match the paper it's attributed to, and we couldn't verify the numbers being repeated. What's genuinely true is that GHK-Cu has well-documented, general dermal remodelling activity, and that mechanism is mechanistically relevant to vascular-type dark circles specifically, not pigmentation or structural volume loss. No dedicated periorbital or dark-circle trial of GHK-Cu exists that we could locate. This is a reasonable thing to try for the right underlying cause, with realistic expectations, not a proven eye-area treatment.
Is the "GHK-Cu eye cream study" real?
The underlying paper is real, but it isn't an eye cream study. It's a 1998 pilot study on general skin ultrastructure, 20 subjects, applied to the thigh, measuring collagen and cell-proliferation markers, not periorbital wrinkles or dark circles. The specific claims commonly attached to it (41 women, 12 weeks, 55% wrinkle reduction) don't match the actual paper.
Will GHK-Cu get rid of my dark circles?
It depends what's causing them. If your dark circles are mainly from thin skin showing underlying blood vessels, GHK-Cu's dermal remodelling mechanism is genuinely relevant. If they're mainly pigmentation or volume loss, it isn't the right mechanism, and no amount of use will change an outcome the mechanism doesn't reach.
How do I know which type of dark circles I have?
A rough self-check: gently stretching the skin can lessen a vascular cast (vessels becoming less visible as skin tautens) but won't change pigmentation. A dermatologist can assess this more reliably, and it's worth doing before investing in any targeted product, copper peptide or otherwise.
Is GHK-Cu safe to use around the eyes?
There's no dedicated periorbital tolerability data for our formula specifically. Use a smaller amount than a facial application, avoid direct contact with the eye, and patch test elsewhere first if you have sensitive skin.
This article is provided for educational purposes and does not constitute medical advice. Avoid direct contact with the eyes. AmpleLab products are cosmetic formulations and are not intended to diagnose, treat, cure, or prevent any condition.
AmpleLab.